Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of 15.73% is 35% below its 5-year average of 24.08%, near the low end of its 5-year range (15.73%–29.72%).
As of the fiscal period ended Tuesday, June 30, 2026. 36.12% below its 12-month average of 24.62%.
Reported quarterly EBITDA margin; no daily interpolation.
EBITDA MARGIN
15.73%
EBITDA MARGIN AVG TTM
24.62%
EBITDA MARGIN AVG 3Y
24.92%
EBITDA MARGIN AVG 5Y
24.43%
EBITDA MARGIN AVG 10Y
24.72%
EBITDA MARGIN AVG 15Y
21.12%
EBITDA MARGIN AVG 20Y
20.61%
CURRENT VS TTM AVG
-36.12%
CURRENT VS 3Y AVG
-36.88%
CURRENT VS 5Y AVG
-35.63%
CURRENT VS 10Y AVG
-36.37%
CURRENT VS 15Y AVG
-25.53%
CURRENT VS 20Y AVG
-23.68%
Boston Scientific Corporation
Market Cap
$69.46B
EBITDA Margin
15.73%
TTM Avg
24.62%
3Y Avg
24.92%
5Y Avg
24.43%
Market Cap
$78.57B
EBITDA Margin
28.74%
TTM Avg
30.12%
3Y Avg
35.91%
5Y Avg
41.00%
Market Cap
$60.00B
EBITDA Margin
23.08%
TTM Avg
23.14%
3Y Avg
23.23%
5Y Avg
22.53%
Market Cap
$87.16B
EBITDA Margin
20.49%
TTM Avg
20.06%
3Y Avg
19.91%
5Y Avg
20.05%
Market Cap
$49.56B
EBITDA Margin
29.55%
TTM Avg
28.88%
3Y Avg
30.96%
5Y Avg
31.73%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Boston Scientific Corporation (BSX) | $69.46B | 15.73% | 24.62% | 24.92% | 24.43% |
| Cigna Corporation (CI)vs › | $73.82B | 4.28% | 4.40% | 4.95% | 5.27% |
| Cencora, Inc. (COR)vs › | $60.57B | 1.46% | 1.44% | 1.41% | 1.40% |
| Regeneron Pharmaceuticals, Inc. (REGN)vs › | $78.57B | 28.74% | 30.12% | 35.91% | 41.00% |
| Becton, Dickinson and Company (BDX)vs › | $60.00B | 23.08% | 23.14% | 23.23% | 22.53% |
| Elevance Health Inc. (ELV)vs › | $81.51B | 4.85% | 5.33% | 5.81% | 6.32% |
| Cardinal Health, Inc. (CAH)vs › | $53.87B | 1.38% | 1.12% | 0.75% | 0.28% |
| HCA Healthcare, Inc. (HCA)vs › | $87.16B | 20.49% | 20.06% | 19.91% | 20.05% |
| Edwards Lifesciences Corporation (EW)vs › | $49.56B | 29.55% | 28.88% | 30.96% | 31.73% |
| IDEXX Laboratories, Inc. (IDXX)vs › | $44.10B | 34.08% | 33.18% | 32.37% | 31.82% |
Gross Margin
71.2%
EBITDA Margin
15.7%
Operating Margin
21.6%
Net Margin
17.5%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2026-06-30 | 15.73% |
| 2026-03-31 | 27.35% |
| 2025-12-31 | 29.72% |
| 2025-09-30 | 27.48% |
| 2025-06-30 | 22.82% |
| 2025-03-31 | 26.18% |
| 2024-12-31 | 20.54% |
| 2024-09-30 | 23.31% |
| 2024-06-30 | 25.68% |
| 2024-03-31 | 24.59% |
| 2023-12-31 | 23.38% |
| 2023-09-30 | 24.35% |
| 2023-06-30 | 23.59% |
| 2023-03-31 | 23.61% |
| 2022-12-31 | 22.92% |
| 2022-09-30 | 23.47% |
| 2022-06-30 | 23.46% |
| 2022-03-31 | 24.16% |
| 2021-12-31 | 23.89% |
| 2021-09-30 | 24.35% |
| 2021-06-30 | 25.15% |
| 2021-03-31 | 22.82% |
| 2020-12-31 | 17.10% |
| 2020-09-30 | 20.42% |
| 2020-06-30 | 10.68% |
| 2020-03-31 | 19.66% |
| 2019-12-31 | 24.13% |
| 2019-09-30 | 24.16% |
| 2019-06-30 | 25.28% |
| 2019-03-31 | 26.39% |
| 2018-12-31 | 26.12% |
| 2018-09-30 | 26.45% |
| 2018-06-30 | 26.67% |
| 2018-03-31 | 27.99% |
| 2017-12-31 | 27.66% |
| 2017-09-30 | 26.37% |
| 2017-06-30 | 26.67% |
| 2017-03-31 | 23.80% |
| 2016-12-31 | 24.28% |
| 2016-09-30 | 25.61% |
| 2016-06-30 | -9.36% |
| 2016-03-31 | 21.84% |
| 2015-12-31 | -6.88% |
| 2015-09-30 | -8.90% |
| 2015-06-30 | 18.18% |
| 2015-03-31 | 7.75% |
| 2014-12-31 | 11.55% |
| 2014-09-30 | 9.37% |
| 2014-06-30 | 2.14% |
| 2014-03-31 | 17.25% |
| 2013-12-31 | 12.68% |
| 2013-09-30 | 11.76% |
| 2013-06-30 | 17.74% |
| 2013-03-31 | -12.89% |
| 2012-12-31 | 11.86% |
| 2012-09-30 | -32.05% |
| 2012-06-30 | -181.24% |
| 2012-03-31 | 15.70% |
| 2011-12-31 | 14.39% |
| 2011-09-30 | 14.46% |
| 2011-06-30 | 16.86% |
| 2011-03-31 | 22.23% |
| 2010-12-31 | 23.98% |
| 2010-09-30 | 19.83% |
| 2010-06-30 | 18.41% |
| 2010-03-31 | -69.29% |
| 2009-12-31 | -52.96% |
| 2009-09-30 | 23.26% |
| 2009-06-30 | 19.33% |
| 2009-03-31 | 6.92% |
| 2008-12-31 | -114.09% |
| 2008-09-30 | 8.04% |
| 2008-06-30 | 21.64% |
| 2008-03-31 | 35.34% |
| 2007-12-31 | -11.89% |
| 2007-09-30 | 0.39% |
| 2007-06-30 | 21.15% |
| 2007-03-31 | 20.95% |
| 2006-12-31 | 22.18% |
| 2006-09-30 | 17.18% |
| 2006-06-30 | -178.20% |
| 2006-03-31 | 33.02% |
| 2005-12-31 | 32.66% |
| 2005-09-30 | -19.13% |
| 2005-06-30 | 22.39% |
| 2005-03-31 | 33.68% |
| 2004-12-31 | 33.38% |
| 2004-09-30 | 26.45% |
| 2004-06-30 | 32.47% |
| 2004-03-31 | 26.43% |
| 2003-12-31 | 23.75% |
| 2003-09-30 | 22.15% |
| 2003-06-30 | 22.72% |
| 2003-03-31 | 21.69% |
| 2002-12-31 | 21.62% |
| 2002-09-30 | 36.70% |
